Nonmelanoma skin cancers (NMSCs) are some of the most commonly diagnosed malignancies. In general, early-stage NMSCs have favorable outcomes; however, a small subset of patients develop resistant, advanced, or metastatic disease, or aggressive subtypes that are more challenging to treat...
This is the library for the Enduring Materials from the Targets for Cancer IO: A Deep Dive, iPSC derived cell therapies webinar that was conducted on September 26, 2022 . Moderators: Kalle Malmberg, MD, PhD - Oslo University Hospital Jeffrey S. Miller, MD - University of...
3 attachments
Immunotherapy has transformed lung cancer care in recent years. In addition to providing durable responses and prolonged survival outcomes for a subset of patients with heavily pretreated non-small cell lung cancer (NSCLC), immune checkpoint inhibitors (ICIs)— either as monotherapy or in...
Presentation slides and video from the 2021-2022 Advances in Cancer Immunotherapy ™ : A Focus on Biomarkers held virtually on March 24, 2022 are available here. Program Organizers Andrew Coveler, MD – University of Washington/Fred Hutchinson Cancer Research Center Mary L...
12 attachments
Presented by PlatformQ in collaboration with the Society for Immunotherapy of Cancer As diagnostic and therapeutic advances intersect, there is a significant impact on oncology patient care and increased the use of molecular testing to guide treatment decision-making. While these practices are...
06-10-2020 | 12:00 - 13:00 ET
Presentation slides and video from the 2019-2020 Advances in Cancer Immunotherapy™ Series - Toronto, ON held virtually on December 8, 2020 are available here. Program Organizers Marcus O. Butler, MD, PhD – Princess Margaret Cancer Centre Pamela Ohashi, PhD – Princess Margaret...
20 attachments
Presentation slides and video from the 2019-2020 Advances in Cancer Immunotherapy™ Series - Washington, DC held virtually on October 8, 2020 are available here. Program Organizers Geoffrey Gibney, MD – Georgetown Lombardi Comprehensive Cancer Center Stephen Liu, MD – Georgetown...
23 attachments
On January 7, 2020, leading experts in cancer immunotherapy presented an overview of the publication "The Society for Immunotherapy of Cancer Consensus Statement on Immunotherapy for the Treatment of Advanced Renal Cell Carcinoma (RCC)" during a live webinar. The recorded webinar and...
2 attachments
Presentation slides and video from the 2019-2020 Advances in Cancer Immunotherapy TM Series - Tampa, FL, held virtually on November 21, 2020 are available here. Program Organizers Marco L. Davila, MD, PhD – Moffitt Cancer Center Jose Lutzky, MD, FACP – University of Miami Sylvester...
17 attachments
Presentation slides and video from the 2020 Advances in Cancer Immunotherapy TM - Charleston, SC, held on February 1, 2020 are available here. Program Organizers David M. Neskey, MD – MUSC Hollings Cancer Center Chrystal M. Paulos, PhD – Medical University of South Carolina ...
19 attachments
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us